The case for Quantum-Leapfrog Crunch, that is an

New Post Public Reply Private Reply Replies (0) Message Board
Puravida19 Crunch55 #6070
721
The case for Quantum-Leapfrog

Crunch, that is an Excellent infographic on Micro-LED
So good I am posting it again for those that might have skipped it -
Micro LED: Understand the New Display Technology in 3 minutes

The importance of micro-LED has been very underreported.

First, it is uses emissive quantum dots in some kind of electrically conductive silicone or polymer. The QD are electrically stimulated to luminesce, hence they are emissive. Emissive QD must meet higher specifications than photoluminescent QD and so are harder to manufacture and presumably would cost more than previous generations of QD. This cost is offset by their higher brightness requiring less QD for similar applications.

Second, Micro-LED are 100 times smaller than regular LED. This is a manufacturing challenge to effect size reduction. This retooling is expensive, but it is offset in that Micro-LED require much fewer layers and no backlight, lowering overall manufacturing expense over time.

Third, from examples I see in papers, Red, Green AND Blue QD are all a requirement. This is the first application commercially proposed to use Blue QD. While QMC has not announced their being able to make Blue QD, Uniglobe-Kisco said it in a marketing blurb for SID-Displayweek upcoming.

Fourth, while there may be a few QD manufacturers presenting at the Micro-LED Forum in Taiwan, none have announced the ability to manufacture Blue QD, and more importantly, the ability to mass-produce them. What does it take to manufacture Blue QD? Why has it not been done commercially prior to now? First, Blue QD would be the smallest size of any QD Color. Red are the biggest, Green are much smaller, and Blue and UV (if possible) would be smaller still, perhaps under 2nm. It is difficult by batch method to time and temperature something that small which requires precision. An automated process can be duplicated. Second, it might require different materials than currently used which would require new science and understanding, a new paradigm for QD manufacture. It might also require different integration into QD products, which is more than just retooling, it is reconceptualization.

Fifth and finally, Apple is reported to be considering using Micro-LED in next gen smartphones. This is a small size application but represents a quantum leap in display technology that would put Apple way ahead in smartphones.
Hundreds of millions of units would be sold yearly. If this technology is near ready for smartphones, and if it is possible to integrate Micro-LED into large screen displays, it has the potential to quantum-leapfrog Samsung's QLED technology for displays that are less expensive to manufacture with much better detail and brightness.

We know the QD display market is only beginning now. Millions of units today will be hundreds of millions in a few years. What better time to adapt a new technology that is the future?

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 20

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading